PROFENAL by Alcon is clinical pharmacology suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. First approved in 1988.
Drug data last refreshed 10h ago · AI intelligence enriched 3w ago
PROFENAL (suprofen) is a non-steroidal anti-inflammatory drug (NSAID) ophthalmic solution approved for intraocular use during cataract surgery. It works by inhibiting cyclooxygenase to reduce prostaglandin-mediated intraocular inflammation and prevent miosis (pupil constriction) during surgery. The drug is administered as topical eye drops to maintain pupil dilation and reduce post-operative inflammation.
As an older specialty ophthalmic product approaching loss of exclusivity, the brand team is likely in maintenance/rationalization mode with limited commercial expansion opportunities.
CLINICAL PHARMACOLOGY Suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. Its mechanism of action is believed to be through inhibition of the cyclooxygenase enzyme that is essential in the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on PROFENAL at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
PROFENAL represents a stable but mature specialty ophthalmic asset with zero current linked job openings, indicating limited hiring. Working on this product offers deep expertise in perioperative ophthalmic care and close relationships with cataract surgeons, but career growth is constrained by the aging patent portfolio and narrow indication.